Calluna Pharma

Calluna Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Our innovative therapeutic approach targets upstream amplifiers of disease offering potential treatments across a diverse array of therapeutic indications. Calluna Pharma is a clinical stage biotech company driven by a commitment to improve patient outcomes in diseases where existing treatments are sub-optimal. We believe in the power of immunology to push boundaries, challenge the status quo, and develop therapies that will make a real difference for people living with serious diseases.

Company Details

Employees
22
Founded
-
Address
Gaustadalléen 21, Oslo,0349,norway
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Oslo
Looking for a particular Calluna Pharma employee's phone or email?

Calluna Pharma Questions

News

Calluna Pharma Announces Initiation of Phase 2 AURORA Study of CAL101 for Idiopathic Pulmonary Fibrosis - Business Wire

Calluna Pharma Announces Initiation of Phase 2 AURORA Study of CAL101 for Idiopathic Pulmonary Fibrosis Business Wire

Calluna Pharma starts efficacy test with unique IPF antibody - European Biotechnology Magazine

Calluna Pharma starts efficacy test with unique IPF antibody European Biotechnology Magazine

Calluna Pharma : Quotes, Address, Contact - News-Medical

Calluna Pharma : Quotes, Address, Contact News-Medical

Calluna Pharma Names CEO - Contract Pharma

Calluna Pharma Names CEO Contract Pharma

Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug - PharmaTimes

Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug PharmaTimes

Calluna Pharma Successfully Completes Phase 1 Clinical Study of CAL101, a First-in-Class Therapeutic for Fibrotic and Fibro-Inflammatory Indications - Business Wire

Calluna Pharma Successfully Completes Phase 1 Clinical Study of CAL101, a First-in-Class Therapeutic for Fibrotic and Fibro-Inflammatory Indications Business Wire

Calluna Pharma Launches and Announces EUR 75 Million Series A Financing to Develop Novel Therapies for Inflammatory and Fibrotic Diseases - Business Wire

Calluna Pharma Launches and Announces EUR 75 Million Series A Financing to Develop Novel Therapies for Inflammatory and Fibrotic Diseases Business Wire

Top Calluna Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant